Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy

[1]  T. D. de Boo,et al.  Immunoglobulin G, A and M Light Chain Ratio in Children , 1992, Annals of clinical biochemistry.

[2]  B. Engelen,et al.  Treatment of idiopathic West- and Lennox epilepsy with intravenous immunoglobulin , 1991, Clinical Neurology and Neurosurgery.

[3]  T. D. de Boo,et al.  Determination of Kappa and Lambda Light Chains in Serum Immunoglobulins G, A and M , 1991, Annals of clinical biochemistry.

[4]  T. Barington,et al.  Distribution of κ and λ Light Chain Isotypes among Human Blood Immunoglobulin‐Secreting Cells after Vaccination with Pneumococcal Polysaccharides , 1989 .

[5]  W. Renier,et al.  Morphological and Biochemical Analysis of a Brain Biopsy in a Case of Idiopathic Lennox‐Gastaut Syndrome , 1988, Epilepsia.

[6]  B. Jasani.  Immunohistologically definable light chain restriction in autoimmune disease , 1988 .

[7]  A. Plebani,et al.  Intravenous gamma-globulin therapy and serum IgG subclass levels in intractable childhood epilepsy. , 1988, Monographs in allergy.

[8]  P. V. VAN MUNSTER,et al.  Nephelometry of the kappa/lambda light-chain ratio in serum of normal and diseased children. , 1986, Clinical chemistry.

[9]  Kimio Ogawa,et al.  HIGH DOSE GAMMAGLOBULIN FOR INTRACTABLE CHILDHOOD EPILEPSY , 1983, The Lancet.

[10]  R. Riikonen.  Infantile Spasms: Some New Theoretical Aspects , 1983, Epilepsia.

[11]  J. Sotelo,et al.  Immunoglobulins in epilepsy , 1982, Journal of the Neurological Sciences.

[12]  A. Moglia,et al.  Immunological findings in epileptic and febrile convulsion patients before and under treatment. , 1981, European neurology.

[13]  R. Heipertz,et al.  Determination of immunoglobulin content of CSF based on light chain characteristics , 1978, Annals of neurology.

[14]  N. Rabinovitch,et al.  Oligoclonal Immunoglobutins, Light Chain Ratios and Free Light Chains in Cerebrospinal Fluid and Serum from Patients Affected with Various Neurological Diseases , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[15]  B. Sauvezie,et al.  [The treatment of epileptic encephalopathies with gamma globulin in children (author's transl)]. , 1977, Revue d'electroencephalographie et de neurophysiologie clinique.

[16]  M. Rapport,et al.  Antiserum to brain gangliosides produces recurrent epileptiform activity. , 1976, Science.

[17]  M. Pasino,et al.  IMMUNOLOGICAL SIDE-EFFECTS OF ANTICONVULSANTS , 1976, The Lancet.

[18]  H. Uchino,et al.  IMMUNODEFICIENCY AND EPILEPSY , 1976, The Lancet.

[19]  J. Wilson,et al.  IgA DEFICIENCY, EPILEPSY, AND PHENYTOIN TREATMENT , 1975, The Lancet.

[20]  T. Sorrell,et al.  Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). , 1971, Lancet.

[21]  V. Nussenzweig,et al.  ANTIHAPTEN ANTIBODY SPECIFICITY AND L CHAIN TYPE , 1967, The Journal of experimental medicine.

[22]  J. Fahey,et al.  Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II). , 1965, The Journal of clinical investigation.